These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9743016)

  • 21. Rheumatoid arthritis complicating adjuvant interferon-alpha therapy for malignant melanoma.
    Johnson DM; Hayat SQ; Burton GV
    J Rheumatol; 1999 Apr; 26(4):1009-10. PubMed ID: 10229440
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical prognostic factors in adjuvant melanoma trial.
    Nathanson L
    J Clin Oncol; 1996 Jun; 14(6):1967-8. PubMed ID: 8656271
    [No Abstract]   [Full Text] [Related]  

  • 23. The adjuvant treatment of malignant melanoma.
    Reintgen D; Kirkwood J
    J Fla Med Assoc; 1997 Mar; 84(3):147-52. PubMed ID: 9143164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant application of interferons.
    el Kassas H; Kirkwood JM
    Semin Oncol; 1996 Dec; 23(6):737-43. PubMed ID: 8970596
    [No Abstract]   [Full Text] [Related]  

  • 25. Adjuvant therapy of melanoma: at what cost?
    Spitler LE
    J Clin Oncol; 2001 Feb; 19(4):1226-8. PubMed ID: 11181688
    [No Abstract]   [Full Text] [Related]  

  • 26. Dose efficacy study of two schedules of high-dose bolus administration of interleukin 2 and interferon alpha in metastatic melanoma.
    Kruit WH; Punt CJ; Goey SH; de Mulder PH; Gratama JW; Eggermont AM; Bolhuis RL; Stoter G
    Br J Cancer; 1996 Sep; 74(6):951-5. PubMed ID: 8826864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant therapy of melanoma.
    Retsas S
    Lancet; 1998 Aug; 352(9129):737-8. PubMed ID: 9729017
    [No Abstract]   [Full Text] [Related]  

  • 28. Strategies for combining chemotherapy and biotherapy in melanoma.
    Buzaid AC
    Cancer Control; 2000; 7(2):185-97. PubMed ID: 10783824
    [No Abstract]   [Full Text] [Related]  

  • 29. Adjuvant therapy of stage IIIb melanoma with interferon alfa-2b: clinical and immunological relevance.
    Doveil GC; Fierro MT; Novelli M; Appino A; Bertero M; Quaglino P; Bernengo MG
    Dermatology; 1995; 191(3):234-9. PubMed ID: 8534942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe loss of vision during adjuvant interferon alfa-2b treatment for malignant melanoma.
    Lohmann CP; Kroher G; Bogenrieder T; Spiegel D; Preuner J
    Lancet; 1999 Apr; 353(9161):1326. PubMed ID: 10218534
    [No Abstract]   [Full Text] [Related]  

  • 31. The skin: an immunoreactive target organ during interleukin-2 administration?
    Dummer R; Miller K; Eilles C; Burg G
    Dermatologica; 1991; 183(2):95-9. PubMed ID: 1743379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term survival after extended surgical resection of melanoma metastasis and immunotherapy.
    Meyer T; Goehl J; Hohenberger W
    Eur J Surg Oncol; 1999 Feb; 25(1):105-6. PubMed ID: 10188869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New approaches to the systemic treatment of melanoma.
    Chowdhury S; Vaughan MM; Gore ME
    Cancer Treat Rev; 1999 Oct; 25(5):259-70. PubMed ID: 10544070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant IFN alpha2 therapy of melanoma.
    Kirkwood JM
    Lancet; 1998 Jun; 351(9120):1901-3. PubMed ID: 9654253
    [No Abstract]   [Full Text] [Related]  

  • 35. Diabetes mellitus in cancer patients treated with combination interleukin 2 and alpha-interferon.
    Whitehead RP; Hauschild A; Christophers E; Figlin R
    Cancer Biother; 1995; 10(1):45-51. PubMed ID: 7780486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of metastasized malignant melanoma].
    Kamanabrou D
    Praxis (Bern 1994); 2001 Mar; 90(10):391-6. PubMed ID: 11305184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined chemotherapy with or without interferon alpha N1 (IFN) for advanced malignant melanoma--a randomized pilot phase III study.
    Gorbonova VA; Egorov GN; Perevodchikova NI; Orel NF
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():310-4. PubMed ID: 10939991
    [No Abstract]   [Full Text] [Related]  

  • 38. [To outwit melanoma with its own tricks].
    Bischoff A
    MMW Fortschr Med; 2003 Apr; 145(15):4-6, 8, 10. PubMed ID: 15104255
    [No Abstract]   [Full Text] [Related]  

  • 39. Neoadjuvant therapy for high-risk bulky regional melanoma.
    Tarhini AA; Pahuja S; Kirkwood JM
    J Surg Oncol; 2011 Sep; 104(4):386-90. PubMed ID: 21858833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapy of cutaneous melanoma].
    Dummer R; Nestle FO; Hofbauer G; Böni R; Burg G
    Ther Umsch; 1998 Aug; 55(8):509-14. PubMed ID: 9757818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.